Stay updated on ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T14:09:40.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed information about a Phase II clinical study for ZEP-3Na, which included specifics on the study design, participant criteria, and treatment protocols for Atopic Dermatitis. The new version introduces a revision number and retains the mention of Atopic Dermatitis and ZEP-003-IL.
    Difference
    36%
    Check dated 2025-04-17T01:46:59.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T17:42:24.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, v2.14.3, replacing the previous version v2.14.2.
    Difference
    0.1%
    Check dated 2025-04-02T03:25:00.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-25T06:13:38.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-11T01:56:26.000Z thumbnail image

Stay in the know with updates to ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial page.